Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer,...
UBS downgraded Pfizer Inc (NYSE:PFE) to Neutral from Buy and cut its price target to $47.00 from $55.00 on Covid-related headwinds and its view that the company's pipeline is...
By Sam Boughedda Pfizer (NYSE:PFE) was downgraded to Neutral from Buy with its price target cut to $47 from $55 by UBS analysts on Thursday. The analysts told investors in a...
"Directed Evolution"? Pfizer R&D Exec Says Covid-19 Created In Wuhan, Is 'Cash Cow' For Company A high-level Pfizer employee was caught on undercover camera by Project Veritas when...
"What About The Sudden Deaths?": Pfizer CEO Confronted At Davos Over COVID-19 Vaccine While attention is now firmly shifting towards the scandalous Covid-19 vaccine rollout (and...
Doctor Calls For Withdrawal Of Pfizer, Moderna COVID-19 Vaccines Following New Research Authored by Zachary Stieber via The Epoch Times (emphasis ours), An American doctor is...
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.
| Average | 55.40 (+25.94% Upside) |
| High | 75.00 |
| Low | 44.00 |
| Price | 43.99 |
| No. of Analysts | 20 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Neutral | Sell | Strong Sell | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Sell |
| Summary | Strong Buy | Buy | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 70.00 | 70.00 | 65.45 | -2.70 | -3.71% | 1.89M | Lagos | |||
| 265.90 | 265.90 | 265.90 | -1.00 | -0.37% | 90.33K | Lagos | |||
| 0.50 | 0.50 | 0.50 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.81 | 0.81 | 0.81 | -0.090 | -10.00% | 2.97M | Lagos | |||
| 30.75 | 30.75 | 30.75 | -0.15 | -0.49% | 110.37K | Lagos | |||
| 24.40 | 24.45 | 24.30 | +0.10 | +0.41% | 8.69M | Lagos | |||
| 1,120.00 | 1,120.00 | 1,120.00 | +39.90 | +3.69% | 14.96K | Lagos | |||
| 41.95 | 41.95 | 41.95 | 0.00 | 0.00% | 304.73K | Lagos | |||
| 17.65 | 17.65 | 17.65 | -1.45 | -7.59% | 18.60K | Lagos | |||
| 22.25 | 22.30 | 22.25 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 11.70 | 11.80 | 11.70 | 0.00 | 0.00% | 15.14M | Lagos | |||
| 5.40 | 5.85 | 5.35 | +0.070 | +1.31% | 26.64M | Lagos | |||
| 2.32 | 2.32 | 2.32 | -0.010 | -0.43% | 47.73K | Lagos | |||
| 228.00 | 228.00 | 228.00 | +4.00 | +1.79% | 145.81K | Lagos | |||
| 1.10 | 1.10 | 1.10 | 0.00 | 0.00% | 100.00K | Lagos |